Completed OBSERVATIONAL NCT01250574

Neutrophil CD64 and Procalcitonin as Novel Biomarkers for Postoperative Infections

Sponsor: University Hospital, Akershus

Conditions Abdominal Infection Bacterial Infection Postoperative Infection

Updated 8 times since 2017 Last updated: Aug 11, 2021 Started: Nov 30, 2010 Primary completion: Jun 30, 2016 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Abdominal Infection and Bacterial Infection and is currently completed. University Hospital, Akershus leads this study, which shows 8 recorded versions since 2010 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Sep 2021 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Sep 2021 [monthly]

Unknown Status
Jul 2018 — Jan 2021 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — Jul 2018 [monthly]

Active Not Recruiting
Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Nov 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Akershus

Data source: University Hospital, Akershus

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway